Inventor · disambiguated record
Kallanthottathil G. Rajeev
Also filed as: RAJEEV KALLANTHOTTATHIL · RAJEEV KALLANTHOTTATHIL G
193 granted patents·105 pending applications·6,006 citations·filing 2001–2025
99Inventor score
Files withALNYLAM PHARMACEUTICALS INC174MANOHARAN MUTHIAH36ARBUTUS BIOPHARMA CORP28VERVE THERAPEUTICS INC15ALNYLAM PHARMACEUTICALS6
Top patents by PatentIndex Score
298 records- 0199US10806791B2Carbohydrate conjugates as delivery agents for oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2018·Granted Oct 20, 2020·14 cites·12 claims
- 0299US9796974B2Modified RNAi agentsALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Oct 24, 2017·119 cites·30 claims
- 0399US9682139B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2015·Granted Jun 20, 2017·46 cites·20 claims
- 0499US9352048B2Carbohydrate conjugates as delivery agents for oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·112 cites·20 claims
- 0599US8344125B2Modified iRNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2009·Granted Jan 1, 2013·103 cites·20 claims
- 0699US8106022B2Carbohydrate conjugates as delivery agents for oligonucleotidesMANOHARAN MUTHIAH·Filed 2008·Granted Jan 31, 2012·588 cites·21 claims
- 0798US11679158B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Jun 20, 2023·7 cites·13 claims
- 0898US11633479B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·11 cites·24 claims
- 0998US11633480B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·11 cites·28 claims
- 1098US11612657B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Mar 28, 2023·9 cites·30 claims
- 1198US11590229B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Feb 28, 2023·11 cites·29 claims
- 1298US11406716B2Modified RNAi agentsALNYLAM PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·8 cites·21 claims
- 1398US11382979B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Jul 12, 2022·18 cites·30 claims
- 1498US11246933B1Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Feb 15, 2022·30 cites·28 claims
- 1598US11110174B2Carbohydrate conjugates as delivery agents for oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2020·Granted Sep 7, 2021·10 cites·20 claims
- 1698US10668170B2Modified RNAi agentsALNYLAM PHARMACEUTICALS INC·Filed 2018·Granted Jun 2, 2020·22 cites·22 claims
- 1798US10612024B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Apr 7, 2020·15 cites·35 claims
- 1898US10612027B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Apr 7, 2020·26 cites·25 claims
- 1998US10369226B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Aug 6, 2019·25 cites·42 claims
- 2098US10233448B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Mar 19, 2019·37 cites·40 claims
- 2198US9867882B2Carbohydrate conjugates as delivery agents for oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Jan 16, 2018·33 cites·29 claims
- 2298US9399775B2RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseasesALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Jul 26, 2016·51 cites·36 claims
- 2398US9345780B2Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic componentsTEKMIRA PHARMACEUTICALS CORP·Filed 2013·Granted May 24, 2016·255 cites·10 claims
- 2498US9249415B2Complement component C5 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Feb 2, 2016·24 cites·30 claims
- 2598US9186325B2Lipids and compositions for the delivery of therapeuticsMANOHARAN MUTHIAH·Filed 2009·Granted Nov 17, 2015·100 cites·19 claims
- 2698US9061063B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Jun 23, 2015·41 cites·32 claims
- 2798US9012498B2Biodegradable lipids for the delivery of active agentsMANOHARAN MUTHIAH·Filed 2011·Granted Apr 21, 2015·104 cites·41 claims
- 2898US8999351B2Lipids and compositions for the delivery of therapeuticsMANOHARAN MUTHIAH·Filed 2009·Granted Apr 7, 2015·102 cites·15 claims
- 2998US8883202B2Lipid compositionsMANOHARAN MUTHIAH·Filed 2010·Granted Nov 11, 2014·104 cites·22 claims
- 3098US8828956B2Carbohydrate conjugates as delivery agents for oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Sep 9, 2014·224 cites·16 claims
- 3198US8809516B2Therapeutic compositionsALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Aug 19, 2014·43 cites·22 claims
- 3298US8642076B2Lipid containing formulationsMANOHARAN MUTHIAH·Filed 2011·Granted Feb 4, 2014·155 cites·28 claims
- 3398US8575123B2Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic componentsMANOHARAN MUTHIAH·Filed 2009·Granted Nov 5, 2013·82 cites·39 claims
- 3498US8450467B2Carbohydrate conjugates as delivery agents for oligonucleotidesMANOHARAN MUTHIAH·Filed 2011·Granted May 28, 2013·227 cites·21 claims
- 3598US8404862B2Ligand-conjugated monomersMANOHARAN MUTHIAH·Filed 2009·Granted Mar 26, 2013·84 cites·40 claims
- 3698US7745608B2Modified iRNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2004·Granted Jun 29, 2010·129 cites·43 claims
- 3798US7723509B2IRNA agents with biocleavable tethersALNYLAM PHARMACEUTICALS·Filed 2004·Granted May 25, 2010·202 cites·41 claims
- 3898US7582744B2Chemically modified oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2005·Granted Sep 1, 2009·177 cites·23 claims
- 3997US11286486B2Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseasesALNYLAM PHARMACEUTICALS INC·Filed 2020·Granted Mar 29, 2022·8 cites·28 claims
- 4097US9764036B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2015·Granted Sep 19, 2017·19 cites·22 claims
- 4197US9708607B2Modified RNAi agentsALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Jul 18, 2017·41 cites·28 claims
- 4297US9682922B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Jun 20, 2017·39 cites·18 claims
- 4397US9394234B2Lipid formulationsTEKMIRA PHARMACEUTICALS CORP·Filed 2014·Granted Jul 19, 2016·117 cites·10 claims
- 4497US9370581B2Carbohydrate conjugates as delivery agents for oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Jun 21, 2016·24 cites·20 claims
- 4597US9290760B2Modified iRNA agentsRAJEEV KALLANTHOTTATHIL G·Filed 2011·Granted Mar 22, 2016·100 cites·33 claims
- 4697US8927513B25′ phosphate mimicsMANOHARAN MUTHIAH·Filed 2010·Granted Jan 6, 2015·108 cites·14 claims
- 4797US8802644B2Lipid formulationCHEN JIANXIN·Filed 2012·Granted Aug 12, 2014·124 cites·35 claims
- 4897US8722082B2Lipids and compositions for the delivery of therapeuticsMANOHARAN MUTHIAH·Filed 2009·Granted May 13, 2014·44 cites·25 claims
- 4997US8507455B2Folate conjugatesMANOHARAN MUTHIAH·Filed 2008·Granted Aug 13, 2013·32 cites·14 claims
- 5097US8158601B2Lipid formulationCHEN JIANXIN·Filed 2010·Granted Apr 17, 2012·777 cites·30 claims
Showing the top 50 of 298 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kallanthottathil G. Rajeev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →